Table 1.

Pretreatment Patient Characteristics in 15 HFRT Trials

Variable	Patients (N)
Age, y (range)
70(63–75)
Clinical stage	752
T1	1024
T2	283
T3
Gleason score
< 6	1250
7	714
8–10	162
PSA
< 10	711
11–20	581
> 20	303
ADT	Trials (N)
Yes	8
No	5
Not reported	2

ADT, androgen deprivation therapy; HFRT, hypofractionated radiotherapy; PSA, prostate-specific antigen.